Publications in collaboration with researchers from Universidad Complutense de Madrid (27)

2024

  1. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

2023

  1. Academic climate and psychopathological symptomatology in Spanish medical students

    BMC Medical Education, Vol. 23, Núm. 1

  2. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

    Clinical Colorectal Cancer, Vol. 22, Núm. 2, pp. 222-230

  3. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  4. Inter-Rater Variability in the Evaluation of Lung Ultrasound in Videos Acquired from COVID-19 Patients

    Applied Sciences (Switzerland), Vol. 13, Núm. 3

  5. Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

    Aging Cell, Vol. 22, Núm. 6

2022

  1. Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry

    United European Gastroenterology Journal, Vol. 10, Núm. 5, pp. 507-517

  2. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    Neurologia, Vol. 37, Núm. 8, pp. 615-630

  3. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    Multiple Sclerosis and Related Disorders, Vol. 63

  4. EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe

    Therapeutic Advances in Gastroenterology, Vol. 15

  5. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  6. Prognostic Significance of the PROFUND Index on One Year Mortality in Acute Heart Failure: Results from the RICA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 7

  7. Upfront primary tumour resection and survival in synchronous metastatic colorectal cancer according to primary tumour location and RAS status: Pooled analysis of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

    European Journal of Surgical Oncology, Vol. 48, Núm. 5, pp. 1123-1132

2021

  1. Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: Study protocol for the SAFO trial

    BMJ Open, Vol. 11, Núm. 8

  2. Obesity and COVID-19. A necessary position statement

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 8, pp. 573-576

2020

  1. ADHD Symptoms, Academic and Social Difficulties in Parents of Children with ADHD

    Psychiatry (New York), Vol. 83, Núm. 3, pp. 231-243

  2. Complement C5 Protein as a Marker of Subclinical Atherosclerosis

    Journal of the American College of Cardiology, Vol. 75, Núm. 16, pp. 1926-1941

2019

  1. A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity

    Obesity Surgery, Vol. 29, Núm. 12, pp. 3842-3853

  2. Outcomes of Bariatric Surgery in Patients with Cirrhosis

    Obesity Surgery, Vol. 29, Núm. 2, pp. 585-592

2018

  1. Exercise-related severe cardiac events

    Scandinavian Journal of Medicine and Science in Sports, Vol. 28, Núm. 4, pp. 1404-1411